CRP and COVID-19: There were major changes in the percentage of patients undergoing troponin dosage (PP ratio=2.02), C-reactive protein dosage (PP ratio=1.53), and full blood count assessment (PP ratio=1.32), while 18,648 patients (27% of the population) had a SARS-CoV-2 polymerase chain reaction test result in the post–COVID-19 period.